Amphastar Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $182.5M | $631.2M | $92.6M |
| FY2021 | $226.0M | $671.5M | $126.4M |
| FY2022 | $213.3M | $742.0M | $156.1M |
| FY2023 | $873.5M | $1.51B | $144.3M |
| FY2024 | $845.2M | $1.58B | $151.6M |